when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked · 2,216 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Marketed
IRBESARTAN
IRBESARTAN
Hypertension Hisun Pharmaceutical USA Inc31 cat
Marketed
enoxaparin sodium
Enoxaparin Sodium Sandoz (enoxaparin sodium)
Deep Vein Thrombosis (DVT) Sandoz Inc2 cat
Marketed
PERAMPANEL
PERAMPANEL
Generalized Seizures$CPRX CATALYST PHARMACEUTICALS, INC.1 cat
Marketed

page 18 of 74

131

Voyxact (sibeprenlimab-szsi)

Sicca Syndrome (Sjogren)

Visterra Inc

1 cat

Marketed

nafarelin acetate

Synarel (nafarelin acetate)

Central Precocious Puberty$PFE PFIZER INC28 cat

Marketed

Tepezza (teprotumumab)

Graves' Ophthalmopathy Horizon Therapeutics USA Inc8 cat

Marketed

(atezolizumab + hyaluronidase (human recombinant))

Tecentriq Hybreza ((atezolizumab + hyaluronidase-tqjs (human recombinant)))

Hepatocellular Carcinoma Genentech Inc5 cat

Marketed

(hyaluronidase (recombinant, human) + nivolumab)

Opdivo Qvantig ((hyaluronidase-nvhy (recombinant, human) + nivolumab))

Adenocarcinoma Of The Gastroesophageal Junction Bristol-Myers Squibb Co5 cat

Marketed

amlodipine besylate

Amlodipine Besylate

Chronic Stable Angina China Resources Saike Pharmaceutical Co Ltd5 cat

Marketed

Verapamil Hydrochloride

Atrial Fibrillation Exela Pharma Sciences LLC2 cat

Marketed

Relapsing Remitting Multiple Sclerosis (RRMS) EMD Serono Inc1 cat

Marketed

Idiopathic Pulmonary Fibrosis$GRI GRI Bio, Inc.1 cat

Marketed

enfortumab vedotin

Padcev (enfortumab vedotin-ejfv)

Muscle Invasive Bladder Cancer (MIBC) Astellas Pharma Inc12 cat

Marketed

ALBUTEROL SULFATE

ALBUTEROL SULFATE

Bronchospasm Sentiss Pharmaceuticals LLC4 cat

Marketed

Hormone Sensitive Breast Cancer Eagle Pharmaceuticals Inc4 cat

Marketed

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) RK Pharma Inc3 cat

Marketed

Muscle Spasticity Beximco Pharmaceuticals USA Inc2 cat

Marketed

Unloxcyt (cosibelimab-ipdl)

Cutaneous Squamous Cell Carcinoma (cSCC) Checkpoint Therapeutics Inc2 cat

Marketed

Retevmo (selpercatinib)

Anaplastic Thyroid Cancer Eli Lilly and Co19 cat

Marketed

Clobetasol Propionate Teva

Clobetasol Propionate

Atopic Dermatitis (Atopic Eczema) Teva Pharmaceuticals USA Inc1 cat

Marketed

no indication$PFE PFIZER INC53 cat

Marketed

ropinirole hydrochloride ER

Ropinirole Hydrochloride

Parkinson's Disease Elite Laboratories Inc11 cat

Marketed

selumetinib sulfate

Koselugo (selumetinib sulfate)

Plexiform Neurofibroma AstraZeneca Pharmaceuticals LP7 cat

Marketed

NILOTINIB HYDROCHLORIDE

NILOTINIB HYDROCHLORIDE

no indication Hetero Labs Ltd2 cat

Marketed

Imdelltra (tarlatamab-dlle)

Small-Cell Lung Cancer$AMGN AMGEN INC2 cat

Marketed

Hyrnuo (sevabertinib)

Non-Small Cell Lung Cancer Bayer AG1 cat

Marketed

PYZCHIVA (USTEKINUMAB-TTWE)

no indication Samsung Bioepis Co Ltd13 cat

Marketed

TAMSULOSIN HYDROCHLORIDE

TAMSULOSIN HYDROCHLORIDE

Storage Symptoms of Benign Prostatic Hyperplasia Synthon Pharmaceuticals Inc (Inactive)2 cat

Marketed

DICHLORPHENAMIDE

DICHLORPHENAMIDE

Hyperkalemic Periodic Paralysis (Primary Hyperkalemic Per… Torrent Pharma Inc1 cat

Marketed

FLUPHENAZINE HYDROCHLORIDE

FLUPHENAZINE HYDROCHLORIDE

no indication Hetero Labs Ltd1 cat